BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 15377362)

  • 1. Atypical moles in a patient undergoing chemotherapy with oral 5-fluorouracil prodrug.
    Fukushima S; Hatta N
    Br J Dermatol; 2004 Sep; 151(3):698-700. PubMed ID: 15377362
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Eruptive multiple lentigo-maligna-like lesions in a patient undergoing chemotherapy with an oral 5-fluorouracil prodrug for metastasizing colorectal carcinoma: a lesson for the pathogenesis of malignant melanoma?
    Bogenrieder T; Weitzel C; Schölmerich J; Landthaler M; Stolz W
    Dermatology; 2002; 205(2):174-5. PubMed ID: 12218237
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Focal acral hyperpigmentation in a patient undergoing chemotherapy with capecitabine.
    Villalón G; Martín JM; Pinazo MI; Calduch L; Alonso V; Jordá E
    Am J Clin Dermatol; 2009; 10(4):261-3. PubMed ID: 19489659
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-SSA/Ro antibody as a risk factor for fluorouracil-induced drug eruptions showing acral erythema and discoid-lupus-erythematosus-like lesions.
    Adachi A; Nagai H; Horikawa T
    Dermatology; 2007; 214(1):85-8. PubMed ID: 17191054
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Photosensitization caused by 5-fluorouracil (5-FU)].
    von Moos R; Sauter C
    Schweiz Med Wochenschr; 1999 Jan; 129(1-2):52. PubMed ID: 10065507
    [No Abstract]   [Full Text] [Related]  

  • 6. Reticulate Hyperpigmentation secondary to 5-fluorouracil and idarubicin.
    Jogi R; Garman M; Pielop J; Orengo I; Hsu S
    J Drugs Dermatol; 2005; 4(5):652-6. PubMed ID: 16167426
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Pigmentation and pigmented lesions of the gingival mucosa].
    Mobio S; Noujeim Z; Boutigny H; Jensen M; Cassia A; Soueidan A
    Rev Belge Med Dent (1984); 2008; 63(1):15-28. PubMed ID: 18754536
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Fixed pigmented erythema caused by levamisole administration].
    Clavère P; Bonnafoux-Clavère A; Delrous JL; Bonnetblanc JM; Olivier JP
    Ann Dermatol Venereol; 1994; 121(3):238-9. PubMed ID: 7832552
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Dark grey hyperpigmentation on the face and neck. Diagnose: Minocycline-induced hyperpigmentation type III].
    Wienrich BG; Bertsch HP; Schön MP; Emmert S
    J Dtsch Dermatol Ges; 2010 Jul; 8(7):544-6. PubMed ID: 20642719
    [No Abstract]   [Full Text] [Related]  

  • 10. 5-Fluorouracil-induced bilateral persistent serpentine supravenous hyperpigmented eruption, bilateral mottling of palms and diffuse hyperpigmentation of soles.
    Suvirya S; Agrawal A; Parihar A
    BMJ Case Rep; 2014 Oct; 2014():. PubMed ID: 25336557
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Atypical toxicity associated with 5-Fluororacil in a DPD-deficient patient with pancreatic cancer. Is ethnicity a risk factor?
    Saif MW; Seller S; Diasio RB
    JOP; 2008 Mar; 9(2):226-9. PubMed ID: 18326935
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Isolated hyperpigmentation of the oral mucosa due to hydroxychloroquine.
    Kalampalikis A; Goetze S; Elsner P
    J Dtsch Dermatol Ges; 2012 Dec; 10(12):921-2. PubMed ID: 23190463
    [No Abstract]   [Full Text] [Related]  

  • 13. Pigmented mammary Paget disease: dermoscopic, in vivo reflectance-mode confocal microscopic, and immunohistochemical study of a case.
    Longo C; Fantini F; Cesinaro AM; Bassoli S; Seidenari S; Pellacani G
    Arch Dermatol; 2007 Jun; 143(6):752-4. PubMed ID: 17576941
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antineoplastic agent-associated serpentine supravenous hyperpigmentation: superficial venous system hyperpigmentation following intravenous chemotherapy.
    Geddes ER; Cohen PR
    South Med J; 2010 Mar; 103(3):231-5. PubMed ID: 20134385
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Images in clinical medicine. Serpentine supravenous hyperpigmentation.
    Chan CC; Lin SJ
    N Engl J Med; 2010 Jul; 363(5):e8. PubMed ID: 20830826
    [No Abstract]   [Full Text] [Related]  

  • 16. Morphologic changes of acquired melanocytic nevi with eccentric foci of hyperpigmentation ("Bolognia sign") assessed by dermoscopy.
    Pizzichetta MA; Massone C; Grandi G; Pelizzo G; Soyer HP
    Arch Dermatol; 2006 Apr; 142(4):479-83. PubMed ID: 16618868
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [5-Fluorouracil-induced reticular hyperpigmentation].
    Sanz-Sánchez T; Córdoba S; Jiménez-Ayala B; Borbujo JM
    Actas Dermosifiliogr; 2008 Sep; 99(7):573-4. PubMed ID: 18682175
    [No Abstract]   [Full Text] [Related]  

  • 18. Eruptive post-chemotherapy in situ melanomas and dysplastic nevi.
    Reutter JC; Long EM; Morrell DS; Thomas NE; Groben PA
    Pediatr Dermatol; 2007; 24(2):135-7. PubMed ID: 17461808
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A case of an adverse reaction to topical 5-fluorouracil in irradiated skin.
    Lambert T; Mullinax K; Smith J
    J Drugs Dermatol; 2006 Mar; 5(3):282-3. PubMed ID: 16573264
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dermatoscopic differences between atypical melanocytic naevi and thin malignant melanomas.
    Fikrle T; Pizinger K
    Melanoma Res; 2006 Feb; 16(1):45-50. PubMed ID: 16432455
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.